Truist Securities Reiterates Buy on Merck & Co, Maintains $122 Price Target
Portfolio Pulse from Benzinga Newsdesk
Truist Securities analyst Robyn Karnauskas has reiterated a 'Buy' rating on Merck & Co (NYSE:MRK) and maintained a price target of $122.
October 06, 2023 | 4:10 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Truist Securities has reiterated a 'Buy' rating on Merck & Co and maintained a price target of $122.
The reiteration of a 'Buy' rating by Truist Securities indicates a positive outlook for Merck & Co. The maintained price target of $122 suggests that the analyst believes the stock has potential for growth. This could lead to increased investor confidence and potentially a rise in the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100